The Nexplanon Implant has been the subject of multiple studies and may be responsible for blood clot injuries or deep implant migration. If you or a loved one were injured due to the Nexplanon implant, you may be legally entitled to receive financial compensation through a Nexplanon lawsuit.
After conducting a comprehensive investigation, the FDA released its latest safety warning regarding Nexplanon implants in March 2016. The FDA warned of migration of the Nexplanon implant within the arm from the insertion site, which may be related to insertion of the implant deeper than is advised. According to the FDA, the implant could migrate within the vessels of the arm, to the chest wall, and even to the pulmonary artery, which, it says, could also be related to deep insertions or intravascular insertion. In cases where severe migration of the Nexplanon implant has occurred, surgical procedures may be needed to remove the device.
The FDA warns that the removal of deeply inserted Nexplanon implants via surgery should be conducted with caution in order to prevent injury to deeper neural or vascular structures in the arm and be performed by healthcare providers familiar with the anatomy of the arm. Additionally, if the implant has migrated to the chest, healthcare providers familiar with the anatomy of the chest should be consulted. The FDA went on to warn that failure to remove the Nexplanon implant could result in continued effects of etonogestrel, such as compromised fertility, ectopic pregnancy, or persistence or occurrence of a drug-related adverse event. In addition to migration, the FDA warned of reports of broken and bent implants in the patient’s arm, which could affect the release rate of etonogestrel. All of these warnings from the FDA resulted in the agency issuing an order for the makers of Implanon to change the device’s label to include these safety warnings.
In addition to migration, corrective surgeries, and broken or bent implants, the FDA also warned of thrombotic and other vascular events as a result of using Nexplanon. The FDA’s safety warning states, “serious arterial thrombotic and venous thromboembolic events, including cases of pulmonary emboli (some fatal), deep vein thrombosis, myocardial infarction, and strokes, in women using etonogestrel implants.” In addition, the FDA warns of Nexplanon-induced immune system disorders as well as skin and subcutaneous tissue disorders. The FDA’s warnings and ordered label changes are extremely serious, as they come after numerous reports of women having to undergo intensive surgeries in order to retrieve and remove Nexplanon implants. These corrective surgeries and other serious adverse reactions have resulted in medical bills, lost wages from having to take off work, as well as pain and suffering. If you were implanted with a Nexplanon device and subsequently had to undergo corrective surgery in order to retrieve and remove the device, the attorneys of Abbott Law Group would like to speak to you today about your legal options.
Like Implanon, Nexplanon is associated with a number of serious health risks, one of the most significant being Nexplanon blood clots. A study published in the British Medical Journal found that Nexplanon significantly increases a woman’s risk of developing blood clots. This particular study was performed on women aged 15 to 41, over a nine-year period of time. None of the women in the study had a history of blood clots or related conditions. Other birth control implants showed no signs of an increased risk of blood clots; however, subcutaneous (under the skin) contraceptives like Nexplanon and Implanon showed a 40% increased risk of developing blood clots. In particular, Nexplanon has been linked to deep vein thrombosis, which is a potentially life-threatening type of blood clot. Deep vein thrombosis typically occurs when a blood clot that forms in a vessel (usually the legs) dislodges itself and flows through the bloodstream. If the clot becomes stuck in the lungs, it can block one’s vital blood flow and result in a pulmonary embolism. Some of the signs and symptoms of Nexplanon deep vein thrombosis include swelling of the legs, pain or tenderness in the legs, red or discolored skin, visible surface veins in the legs, tiredness in the legs, and warmth in the skin. If you experience Nexplanon blood clots or deep vein thrombosis after being implanted with a Nexplanon device, contact the attorneys of Abbott Law Group today.
There have been many risks and side effects reported by users of Nexplanon as well as from scientific studies on the birth control implant. Some of the side effects of Nexplanon include:
If you experience any of the adverse side effects of Nexplanon, it is important that you contact your doctor or healthcare professional immediately. After speaking with a doctor, contact the Nexplanon attorneys of Abbott Law Group to discuss what possible legal actions you may have against Merck & Co.
Nexplanon, a popular etonogestrel contraceptive implant, is a small, soft, and flexible birth control implant that is placed under the skin of a woman’s upper arm in order to prevent pregnancies. The toothpick-sized implant works to prevent pregnancies for up to three years by slowly releasing a synthetic hormone called etonogestrel into the body. The slow release of etonogestrel into a woman’s system inhibits ovulation and thickens the cervical mucus thereby preventing pregnancies.
Approved by the Food and Drug Administration (FDA) in 2011, Nexplanon is a newer version of Implanon with some small differences. Nexplanon unique from other birth control implants in that it is radiopaque, meaning it is visible through the use of X-ray technology, which allows physicians to ensure proper placement of the implant. This new characteristic allows doctors the ability to determine if the implant has been properly placed in the arm, and if the device migrates from the insertion point then an x-ray could help a doctor find the device.
However, despite some improvements of Implanon through the release of Nexplanon, the birth control device still carries with it serious risks of adverse side effects. Currently, many women are filing Nexplanon lawsuits against Merck & Co., the manufacturer of Nexplanon, after the birth control implant contributed to the development of severe blood clots. If you or a loved one have suffered from any serious adverse side effects after using Nexplanon, contact the attorneys of Abbott Law Group today for a free case evaluation.
Marketed and sold by Merck & Co., Nexplanon was approved by the FDA in 2011 and is used by hundreds of thousands of American women. Nexplanon is a matchstick-sized rod, approximately four centimeters long and two millimeters in diameter, which is inserted under the skin of the upper arm. Once inserted, the implant slowly releases etonogestrel into the body, which inhibits ovulation and thickens the cervical mucous thereby preventing pregnancies. Lasting up to three years after insertion, Nexplanon is considered a type of long-acting reversible contraception, which has shown to be the most effective form of birth control available. The failure rate of Nexplanon is reportedly just .05%, although, there have been some reports of women getting pregnant while using the implant.
Nexplanon is the newest version of Implanon, improving on its predecessor in a few small ways. The difference between the two implants is that Nexplanon is radio-opaque (containing barium-sulfate) so that a healthcare professional can use an x-ray or CT scan to locate the device after it is implanted. The other major difference is that it has a new preloaded applicator, which makes implanting easier and reduces the risk of implantation errors. While Nexplanon is an improvement of Implanon, the National Center for Biotechnology Information found that it has a safety and efficacy profile comparable to Implanon. This is quite alarming considering the recent reports from consumers and resulting studies of Implanon and other etonogestrel contraceptive implant that have linked it to blood clots, deep vein thrombosis, migration of the implant, and many other serious adverse side effects. The fact that Merck & Co. has improved on Implanon in certain, small ways by releasing Nexplanon, but not greatly improved on the implant’s safety and effectiveness has raised concerns of the FDA as well as healthcare experts nationwide.
As a result of the FDA safety warnings and label changes, as well as the numerous studies on Nexplanon, many consumers of the birth control implant are filing Nexplanon lawsuits against Merck & Co. Plaintiffs in these lawsuits claim that Merck & Co. failed to adequately warn of the health risks of using Nexplanon.
If you or a loved one were treated with a Nexplanon implant or a similar device and subsequently experienced implant migration, underwent corrective surgery to retrieve and remove the device, or developed blood clots or deep vein thrombosis, you may be legally entitled to compensation for past and future medical bills, lost wages, pain and suffering, and other damages.